Rinker Brian, Thornton Brian P
From the *Department of Surgery, Division of Plastic Surgery, University of Kentucky, Lexington, KY; and †The Kentucky Aesthetic Plastic Surgery Institute, Louisville, KY.
Ann Plast Surg. 2014;72(6):S158-64. doi: 10.1097/01.sap.0000435768.51143.c9.
Skin-sparing mastectomy (SSM) with immediate tissue expander reconstruction poses a challenge in the patient with macromastia or excessive ptosis. Skin reduction via the Wise pattern has been described but is associated with high rates of skin necrosis. The study group consisted of 43 women with grade 2 or 3 ptosis who underwent SSM and immediate reconstruction with tissue expanders, using the Passot (horizontal) skin reduction pattern. Age ranged from 31 to 67 years (mean, 51 years). The endpoints measured were time to final expansion, mastectomy skin flap necrosis, infectious complications, and total complications. Thirty reconstructions were bilateral and 13 were unilateral (73 breasts total). Follow-up ranged from 6 to 55 months (mean, 20). Common comorbid conditions included hypertension (n = 16), obesity (n = 22), and smoking (n = 9). The mean body mass index was 30.6 (range, 19.4-58.6). Twenty-one patients underwent chemotherapy; 12 received radiation. The mean initial fill was 196 mL (range, 0-420 mL), and the mean time to final expansion was 84 days (range, 28-225 days). Five patients did not complete the reconstruction, 2 because of cancer recurrence and 3 because of infection. There were 3 cases of mastectomy flap necrosis occurring after tissue expander placement (7%). There were 7 infectious complications (16%). The use of a horizontal breast reduction pattern at the time of expander placement produces consistently good esthetic outcomes and a low rate of skin necrosis, and it should be considered as an option in patients with macromastia or ptosis undergoing SSM and immediate reconstruction.
对于巨乳症或乳房过度下垂的患者,保留皮肤的乳房切除术(SSM)并立即进行组织扩张器重建是一项挑战。通过Wise术式进行皮肤缩减已有报道,但皮肤坏死率较高。研究组由43例2级或3级乳房下垂的女性组成,她们接受了SSM并使用Passot(水平)皮肤缩减模式立即进行组织扩张器重建。年龄范围为31至67岁(平均51岁)。测量的终点指标包括最终扩张时间、乳房切除皮瓣坏死、感染并发症和总并发症。30例重建为双侧,13例为单侧(共73个乳房)。随访时间为6至55个月(平均20个月)。常见的合并症包括高血压(n = 16)、肥胖(n = 22)和吸烟(n = 9)。平均体重指数为30.6(范围为19.4 - 58.6)。21例患者接受了化疗;12例接受了放疗。平均初始填充量为196 mL(范围为0 - 420 mL),平均最终扩张时间为84天(范围为28 - 225天)。5例患者未完成重建,2例因癌症复发,3例因感染。组织扩张器置入后有3例乳房切除皮瓣坏死(7%)。有7例感染并发症(16%)。在置入扩张器时采用水平乳房缩减模式可始终产生良好的美学效果且皮肤坏死率低,对于接受SSM并立即重建的巨乳症或乳房下垂患者,应将其视为一种选择。